Da Nang Pharmaceutical Medical Equipment JSC
UUPCOM:DDN8,100.00
VND
+200.00
(+2.53%)
ISIN
VN000000DDN5
Return %
Stock
S&P 500
1Y
37.29
14.20
3Y
0.06
81.12
5Y
-55.24
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Da Nang Vietnam
- IPO Date
- Jun 24, 2009
- Website
- dapharco.com.vn
- Similar Companies
- Business
- Da Nang Pharmaceutical - Medical Equipment Joint Stock Company (DAPHARCO), trading under the ticker UPCOM:DDN, is a Vietnam-based healthcare enterprise primarily engaged in the distribution, wholesale, retail, and import-export of pharmaceutical products, medical equipment, healthcare consumables, and dietary supplements. Founded in 1975 and headquartered in Da Nang, Vietnam, the company serves as a leading medical and pharmaceutical distributor throughout Central Vietnam, the Central Highlands, and nationwide markets. The company operates through three principal business segments: Pharmaceutical Products, Medical Equipment and Consumables, and Retail and Logistics Services. Its diversified product and service portfolio comprises: prescription and over-the-counter (OTC) pharmaceutical drugs covering therapeutic areas such as antibiotics, cardiovascular agents, analgesic and anti-inflammatory medications, gastrointestinal therapies, respiratory treatments, and dermatology; traditional and herbal medicinal formulations; dietary supplements, multivitamins, and functional health foods; medical machinery and diagnostic equipment, including patient monitors, diagnostic imaging devices, surgical equipment, and clinical laboratory analyzers; hospital consumables and disposables, such as surgical dressings, disposable syringes, infusion sets, catheter supplies, medical gloves, and personal protective equipment; diagnostic test kits, laboratory reagents, and biochemical supplies; as well as dermocosmetics, personal care goods, and mother-and-baby healthcare products. In addition, the company offers specialized healthcare supply chain services, including Good Storage Practice (GSP)-compliant temperature-controlled warehousing, cold chain management, and regulatory import consultancy. DAPHARCO supplies institutional clients including central and provincial public hospitals, private medical clinics, preventive medicine centers, and research laboratories, alongside commercial clients consisting of wholesale dealers and independent retail pharmacies. The company maintains an extensive distribution network anchored by GDP-certified (Good Distribution Practice) central warehouses, specialized transport fleets, and an expanding network of GPP-certified (Good Pharmacy Practice) retail drugstores operating under the DapharcoBLU brand. The enterprise also acts as an authorized importer and commercial representative for domestic and multinational healthcare corporations. In recent corporate and operational developments, DAPHARCO has accelerated strategic partnerships with international pharmaceutical manufacturers and medical device producers to expand its exclusive distribution rights for advanced therapeutic drugs, biologics, and specialized hospital equipment across the Central Vietnam region. The company has implemented significant digital transformation initiatives, deploying upgraded Enterprise Resource Planning (ERP) systems and an integrated B2B digital procurement platform to streamline supply chain transparency and automated ordering for retail pharmacy partners. Operationally, the company has upgraded its cold storage and GSP warehouse infrastructure to enhance capacity for temperature-sensitive pharmaceuticals and diagnostic reagents, while continuing the strategic restructuring and modernization of its DapharcoBLU retail chain and strengthening its participation in competitive public hospital supply tenders.